Placenta Accreta Spectrum Outcomes with a Multidisciplinary Team and Standardized Ultrasound Approach
American Journal of Perinatology · 01.03.2026 · 43 (04) · 461-471
DOI: 10.1055/a-2626-3120 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.03.2026. Verfasst von Elise A Rosenthal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, UT Southwestern Medical Center, Dallas, Texas. Hauptthemen laut MEDLINE: Patient Care Team, Placenta Accreta, Ultrasonography, Prenatal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
This study aimed to compare outcomes before and after starting a multidisciplinary PAS team with a standardized ultrasound approach. Retrospective cohort study of deliveries ≥ 24 weeks complicated by PAS from August 2009 to April 2022 at a large tertiary care hospital. The multidisciplinary team started in October 2020, and a standardized ultrasound approach was consistently practiced. We compared demographics and pregnancy characteristics before and after the formation of the PAS team. Statistical analysis included Fisher's exact test and χ 2 for categorical variables student's t-test and Kruskal–Wallis test for continuous variables. Of 244 patients, 32 delivered with and 212 delivered before the PAS team. Median gestational age at delivery did not change (37 [36–38] vs. 37 [36–37] weeks before the team, p = 0.680). With the team, 31/32 cases of PAS were prenatally diagnosed (97%) compared with 177/212 (83%) before the team (p = 0.058). There were more cases of false positive prenatal suspicion present with the team (11% vs. 31%). Fewer hysterectomies occurred with the team at 21 (66%) versus 197 (93%) before the team, (p < 0.001). Pathologic severity in hysterectomy specimens significantly differed (p = 0.032), with 10 cases with negative pathology before and none with the team. Due to the lower rate of hysterectomy, the overall median EBL was lower with the team (p = 0.018), but other outcomes were similar. This difference in EBL did not persist when limiting to hysterectomy cases. Maternal LOS overall (6 [5–9] vs. 8 [5–15] days, p = 0.031) and within hysterectomies (6 [5–8] vs. 9 [6–16] days, p = 0.042) was significantly shorter with the team. A multidisciplinary PAS team with a standardized ultrasound approach decreased unnecessary hysterectomies and reduced the length of stay at a large tertiary hospital. A higher rate of false positive prenatal suspicion was observed. This finding supports a need for improved prenatal diagnosis to enable better preoperative risk stratification and planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, UT Southwestern Medical Center, Dallas, Texas.
- Parkland Health, Dallas, Texas.
- Department of Pathology, UT Southwestern Medical Center, Dallas, Texas.
ORCID-Profile: Jessica E Pruszynski, Christina L Herrera
Förderung
- NICHD NIH HHS
Zitieren
APA
Rosenthal, E. A., Lafferty, A. K., Pruszynski, J. E., Uddin, N., Spong, C. Y., & Herrera, C. L. (2026). Placenta Accreta Spectrum Outcomes with a Multidisciplinary Team and Standardized Ultrasound Approach. American Journal of Perinatology, 43(04), 461-471. https://doi.org/10.1055/a-2626-3120
Vancouver
Rosenthal EA, Lafferty AK, Pruszynski JE, Uddin N, Spong CY, Herrera CL. Placenta Accreta Spectrum Outcomes with a Multidisciplinary Team and Standardized Ultrasound Approach. American Journal of Perinatology. 2026;43(04):461-471. doi:10.1055/a-2626-3120
BibTeX
@article{Rosenthal2026,
author = {Rosenthal, Elise A and Lafferty, Ashlyn K and Pruszynski, Jessica E and Uddin, Naseem and Spong, Catherine Y and Herrera, Christina L},
title = {Placenta Accreta Spectrum Outcomes with a Multidisciplinary Team and Standardized Ultrasound Approach},
journal = {American Journal of Perinatology},
year = {2026},
volume = {43},
number = {04},
pages = {461--471},
doi = {10.1055/a-2626-3120}
}
EUVIMED